Skip to main content

Advertisement

Log in

Assessment of the clinical usefulness of serum ribonuclease assays: An indicator for the detection of pancreatic cancer

  • Original Article
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

To evaluate diagnostic usefulness for pancreatic cancer, serum ribonuclease (RNase) level was determined in the three groups of subjects; 1) normal volunteers as control, 2) patients with histologically determined pancreatic cancer, and 3) patients with miscellaneous diseases other than pancreatic cancer.

A small increase of RNase values was recognized with age in the normal subjects and in the patients with nonpancreatic diseases, if renal function was normal. The mean RNase level in the control subjects was 97±41.2units.

A marked elevation of serum RNase level was demonstrated in the patients with pancreatic cancer (p< 0.001) and in the patients with renal dysfunction, but no significant rise was noticed in the patients with pancreatitis. Mean values of RNase in the patients with pancreatic cancer and renal dysfunction were 368±146 units and 342±78.1 units respectively. RNase values above 300 units were recognized in 15(71%)out of 21 patients with pancreatic cancer.

Seven cases with elevated RNase over 300 units other than non-pancreatic malignancy and renal dysfunction were noticed in 6 instances of obstructive jaundice and in one instance of early gastric cancer (an 84-yearold male).

The above-stated findings indicate that serum RNase determination can be utilized as a diagnostic indicator for pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Metais P, et al: Activite ribonucleasique du serum humain. Bull Soc Chim Biol (Paris) 37: 999, 1955

    CAS  Google Scholar 

  2. Houck JC, et al: Serum ribonuclease activity. J Appl Physiol 12: 473, 1958

    PubMed  CAS  Google Scholar 

  3. Migliarese JF: Serum ribonuclease in the cancer patient. Proc Am Assoc Cancer Res 2: 327, 1958

    Google Scholar 

  4. Rabinovitch M, et al: Plasma ribonuclease activity in human uremia. J Lab Clin Med 53: 563, 1959

    PubMed  CAS  Google Scholar 

  5. Hisada T: Changes of ribonuclease activity in serum and urine during the course of surgical treatment for the diagestive organ cancer and other diseases. Iryo 23: 615, 1969 Jpn)

    Google Scholar 

  6. Ressler N, et al: Investigation of ribonuclease isozymes by an electrophoretic ultra-violet method. Nature 210: 695, 1966

    Article  PubMed  CAS  Google Scholar 

  7. Zytko J, et al: Serum ribonuclease in patients with malignant disease. Can Med Assoc J 86: 482, 1962

    Google Scholar 

  8. Chretien PB, et al: Serum ribonucleases in cancer: Relations to tumor histology. Cancer 31: 175, 1973

    Article  PubMed  CAS  Google Scholar 

  9. Levy AL, et al: Serum ribonuclease levels in malignant and nonmalignant diseases. (abstr.) Proc Am Assoc Cancer Res 3: 36, 1959

    Google Scholar 

  10. Levy AL, et al: Effect of disease states on the ribonuclease concentration of body fluid. Clin Chem 6: 43, 1960

    PubMed  CAS  Google Scholar 

  11. Aleksandrowicz J, et al: Disorders of ribonuclease activity in chronic granulocytic leukemia. (cited from 8) Acta Med Pol 7: 299, 1966

    PubMed  CAS  Google Scholar 

  12. Udolf E, et al: Activity of nucleases in plasmocytic reticuloma. Pol Tyg Lek 23: 640, 1968 (cited from 8)

    PubMed  CAS  Google Scholar 

  13. Fink K, et al: Serum ribonuclease in multiple myeloma. Am J Med 50: 450, 1971

    Article  PubMed  CAS  Google Scholar 

  14. Roth JS: Ribonuclease VII. Partial purification and characterization of a ribonuclease inhibitor in rat liver supernatant. J Biol Chem 231: 1085, 1958

    PubMed  CAS  Google Scholar 

  15. Rahman YE: Existence of a third ribonuclease in rat liver particulates. Biochem Biophys Acta 119: 470, 1966

    PubMed  CAS  Google Scholar 

  16. Carter BG, et al: Immunochemical analysis of the multiple forms of bovine ribonuclease. Ann NY Acad Sei 94: 1004, 1961

    Article  CAS  Google Scholar 

  17. Albinus RN: Isolation of salivary ribonuclease, deoxyribonuclease and amylase from the parotid gland of the rat. Biochem Biophys Acta 341: 305, 1974

    Google Scholar 

  18. Frank JJ, et al: Properties of a human liver ribonuclease. J Biol Chem 251: 5745, 1976

    PubMed  CAS  Google Scholar 

  19. Reddi KK: Human granulocyte ribonuclease. Biochem Biophys Res Commun 68: 1119, 1976

    Article  PubMed  CAS  Google Scholar 

  20. Reddi KK: Nature and possible origin of human serum ribonuclease Biochem Biophys Res Commun 67: 110, 1975

    Article  PubMed  CAS  Google Scholar 

  21. Reddi KK, et al: Elevated serum ribonuclease in patients with pancreatic cancer. Proc Nat Acad Sei USA 73: 2308, 1976

    Article  CAS  Google Scholar 

  22. Connolly JH, et al: Ribonuclease in normal and uremic human blood. Brit J Exp Path 43: 402, 1962

    PubMed  CAS  Google Scholar 

  23. Shenkin A, et al: An assessment of the clinical usefulness of plasma ribonuclease assays. Clin Chim Acta 72: 223, 1976

    Article  PubMed  CAS  Google Scholar 

  24. Coombes EJ, et al: Age and sex related reference values for serum ribonuclease. Clin Chim Acta 79: 271, 1977

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakane, H., Yoshida, M. & Murakami, T. Assessment of the clinical usefulness of serum ribonuclease assays: An indicator for the detection of pancreatic cancer. Gastroenterol Jpn 14, 55–62 (1979). https://doi.org/10.1007/BF02774605

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02774605

Key Words

Navigation